Rachel has unique experience spanning respiratory medical research and commercial development in the medical device industry.
Rachel trained in respiratory measurement at the Royal Brompton Hospital, London and subsequently gained a PhD in Pre-Clinical Medicine at St Georges Hospital Medical School, London under the direction of Professor Paul W. Jones. Her research centered on the ground breaking area of dyspnoea perception and measurement. During this time, she published and presented widely in the field. Moving into the commercial world, she became founding director of a scientific and IT SME, gaining wide ranging commercial experience.
For the past 4 years she has worked as Development Manager for Telehealth with innovative medical device company Docobo Ltd, initiating and managing both commercial partner relationships and a number of pilots with clinical teams across the UK.
"I am very excited to join the PneumaCare team at this exciting stage of the company’s development", said Rachel Wilson, new Clinical Manager of the Cambridge-based company." PneumaCare’s highly innovative technology in non-invasive measurement presents a tremendous breakthrough in respiratory measurement.
Mark Harwood, CEO for PneumaCare, welcomes the arrival of Rachel at a key time for the companies new momentum and direction. “We are progressing our commercial activities rapidly and have embarked on several important clinical studies around the world and Rachel’s experience will be vital to ensure we manage our clinical relationships and activities in a timely and professional way, adding further clinical efficacy of our ground breaking respiratory measuring technology”.
About PneumaCare
PneumaCare is a Cambridge (UK)-based company providing clinicians with respiratory diagnostic and monitoring equipment using novel 3D-imaging technology. Thora-3DI™ and PneumaScan™ are CE mark approved and are already being used in clinics, pre- and post-operative assessments, drug testing, and device development by both public and private health care providers. Further
applications of PneumaCare’s proprietary Structured Light Plethysmography technology, developed in close partnership with the clinical community, include home care, neonatal, critical care, and rehabilitation applications.
PneumaCare was founded in 2009 to address directly the needs of respiratory clinicians.
510(k) Approval Pending
*******
For more information please contact:
Dr. Bill Mason
Chairman
PneumaCareLimited
St John’s Innovation Centre
Cowley Road
Cambridge CB4 0WS
United Kingdom
Tel: +44 (0) 1223 703 151
Mob: +44 7785 950134
www.pneumacare.com
[email protected]
Twitter: @Pneumacare
_______________________________________